AB045. Novel gene therapy for erectile dysfunction
Clinical Trial on Systemic / IV, published in Transl Androl Urol (2015) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Clinical Trial
- Journal
- Transl Androl Urol (2015)
- Reported sample size
- —
- Source database
- Europe PMC
- PMCID
- PMC4708833
Abstract (original English)
Objective Erectile dysfunction (ED) is a major health problem that affects millions of men all around the world. Since a significant number of ED patients have a poor response to the first line oral phosphodiesterase 5 inhibitors, underlying treatment like gene therapy is needed to evolve as a promising solution. Methods Basic and clinical researches regarding the application of gene therapy for ED over this few decades were reviewed. Then we summarize the state-of-the-art development of therapeutic targets, transfection methods, model systems and their efficacy in this field. Results All gene therapy studies are still in preclinical phase except one clinical trial using the target of Ca2+-activated, large-conductance K+ channel. In basic researches, animal models of ED induced by aging, diabetes, cavernous nerve injury, hypertension, hypercholesterolemia have been utilized to evaluate the capacities and mechanisms of therapeutic targets to improve ED. In addition to the classic transfection methods like naked plasmid DNA, liposome and virus, new gene therapy vectors such as stem cells come into stage and present specific advantages. Besides, novel systems are invented to optimize the process of transfection. These researches demonstrate that current selected targets are widely involved in multiple erection related signaling pathways and all of them present exciting results. Al
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewEurope PMC
The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review
Systematic Review on Type 2 Diabetes, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level AMeta-analysisEurope PMC
Single cell transcriptomics of human weight loss links adipocyte NPY1R to control of lipolysis
Meta-analysis on Systemic / IV, published in Mol Metab (2026) — summary generated from the PubMed abstract.
- 2026
Mol Metab - Level ASystematic ReviewPubMed
Clinical Applications of Autologous Fat Grafting in Pathological Hand Conditions.
Systematic Review with a reported sample of 7 on Osteoarthritis, Scar, published in J Hand Surg Asian Pac Vol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 7
J Hand Surg Asian Pac Vol - Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level ASystematic ReviewEurope PMC
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives
Systematic Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci2 citations